White House

Milestones :: Perspectives :: Research

 

White House

National Strategy for the COVID-19 Response and Pandemic Preparedness
January 2021 :: 200 pages
The American people deserve an urgent, robust, and professional response to the growing public health and economic crisis caused by the coronavirus (COVID-19) outbreak. President Biden believes that the federal government must act swiftly and aggressively to help protect and support our families, small businesses, first responders, and caregivers essential to help us face this challenge, those who are most vulnerable to health and economic impacts, and our broader communities – not to blame others or bail out corporations.
The Biden-Harris administration will always:
:: Listen to science
:: Ensure public health decisions are informed by public health professionals
:: Promote trust, transparency, common purpose, and accountability in our government
Plan PDF: https://www.whitehouse.gov/wp-content/uploads/2021/01/National-Strategy-for-the-COVID-19-Response-and-Pandemic-Preparedness.pdf

 

::::::

Executive Order on Establishing the COVID-19 Pandemic Testing Board and Ensuring a Sustainable Public Health Workforce for COVID-19 and Other Biological Threats
January 21, 2021 • Presidential Actions

Readout of Vice President Harris’s Call with World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus
January 21, 2021 • Presidential Actions

National Security Directive on United States Global Leadership to Strengthen the International COVID-19 Response and to Advance Global Health Security and Biological Preparedness
January 21, 2021 • Presidential Actions
… Section 1.  Strengthening and Reforming the World Health Organization.  On January 20, 2021, the United States reversed its decision to withdraw from the World Health Organization (WHO) by submitting a letter to the United Nations Secretary-General informing him of the President’s decision that the United States will remain a member of the organization.  Accordingly, the Assistant to the President for National Security Affairs (APNSA) shall, in coordination with the Secretary of State, the Secretary of Health and Human Services (HHS), the heads of other relevant executive departments and agencies (agencies), and the Coordinator of the COVID-19 Response and Counselor to the President (COVID-19 Response Coordinator), provide to the President within 30 days of the date of this directive recommendations on how the United States can:  (1) exercise leadership at the WHO and work with partners to lead and reinvigorate the international COVID-19 response; (2) participate in international efforts to advance global health, health security, and the prevention of future biological catastrophes; and (3) otherwise strengthen and reform the WHO…

Executive Order on Ensuring an Equitable Pandemic Response and Recovery
January 21, 2021 • Presidential Actions

Executive Order on a Sustainable Public Health Supply Chain
January 21, 2021 • Presidential Actions

Memorandum to Extend Federal Support to Governors’ Use of the National Guard to Respond to COVID-19 and to Increase Reimbursement and Other Assistance Provided to States
January 21, 2021 • Presidential Actions

Executive Order on Ensuring a Data-Driven Response to COVID-19 and Future High-Consequence Public Health Threats
January 21, 2021 • Presidential Actions

Executive Order on Improving and Expanding Access to Care and Treatments for COVID-19
January 21, 2021 • Presidential Actions

Executive Order on Promoting COVID-19 Safety in Domestic and International Travel
January 21, 2021 • Presidential Actions

Executive Order on Organizing and Mobilizing the United States Government to Provide a Unified and Effective Response to Combat COVID-19 and to Provide United States Leadership on Global Health and Security
January 20, 2021 • Presidential Actions

 

::::::

Janet Woodcock M.D.
Acting Commissioner of Food and Drugs – Food and Drug Administration
Janet Woodcock was named Acting Commissioner of Food and Drugs on January 20, 2021.
As Acting Commissioner, Dr. Woodcock oversees the full breadth of the FDA portfolio and execution of the Federal Food, Drug, and Cosmetic Act and other applicable laws. This includes assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices; the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation; and the regulation of tobacco products…